MONOCLONAL ANTIBODIES TO CD4
- 1 August 1998
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 24 (3) , 567-578
- https://doi.org/10.1016/s0889-857x(05)70026-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Expression of the Activation Antigen CD27 in Rheumatoid ArthritisClinical Immunology and Immunopathology, 1996
- Treatment of severe cutaneous lupus erythematosuswith a chimeric CD4 monoclonal antibody, cM-T412Journal of the American Academy of Dermatology, 1996
- Physiological T-Cell Death: Susceptibility is Modulated by Activation, Aging, and Transformation, but the Mechanism is ConstantImmunological Reviews, 1994
- Treatment of Rheumatoid Arthritis with a Chimeric CD4 Monoclonal Antibody (cM‐T412): Immunopharmacological Aspects and Mechanisms of ActionScandinavian Journal of Immunology, 1994
- Signal transduction by lymphocyte antigen receptorsCell, 1994
- From Antilymphocyte Serum to Therapeutic Monoclonal Antibodies: First Experiences with a Chimeric CD4 Antibody in the Treatment of Autoimmune DiseaseImmunological Reviews, 1992
- INDUCTION OF DONOR-SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI-CD4 MONOCLONAL ANTIBODY THERAPYTransplantation, 1990
- Monoclonal antibodies and arthritisInflammation Research, 1990
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984